Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

SERPINB3/B4 contributes to early inflammation and barrier dysfunction in an experimental murine model of atopic dermatitis.

Sivaprasad U, Kinker KG, Ericksen MB, Lindsey M, Gibson AM, Bass SA, Hershey NS, Deng J, Medvedovic M, Khurana Hershey GK.

J Invest Dermatol. 2015 Jan;135(1):160-9. doi: 10.1038/jid.2014.353. Epub 2014 Aug 11.

2.

A nonredundant role for mouse Serpinb3a in the induction of mucus production in asthma.

Sivaprasad U, Askew DJ, Ericksen MB, Gibson AM, Stier MT, Brandt EB, Bass SA, Daines MO, Chakir J, Stringer KF, Wert SE, Whitsett JA, Le Cras TD, Wills-Karp M, Silverman GA, Khurana Hershey GK.

J Allergy Clin Immunol. 2011 Jan;127(1):254-61, 261.e1-6. doi: 10.1016/j.jaci.2010.10.009. Epub 2010 Dec 3.

3.

Exacerbation of allergen-induced eczema in TLR4- and TRIF-deficient mice.

Brandt EB, Gibson AM, Bass S, Rydyznski C, Khurana Hershey GK.

J Immunol. 2013 Oct 1;191(7):3519-25. doi: 10.4049/jimmunol.1300789. Epub 2013 Aug 30.

4.

Selective ablation of Ctip2/Bcl11b in epidermal keratinocytes triggers atopic dermatitis-like skin inflammatory responses in adult mice.

Wang Z, Zhang LJ, Guha G, Li S, Kyrylkova K, Kioussi C, Leid M, Ganguli-Indra G, Indra AK.

PLoS One. 2012;7(12):e51262. doi: 10.1371/journal.pone.0051262. Epub 2012 Dec 20.

5.

IL-13Rα2 has a protective role in a mouse model of cutaneous inflammation.

Sivaprasad U, Warrier MR, Gibson AM, Chen W, Tabata Y, Bass SA, Rothenberg ME, Khurana Hershey GK.

J Immunol. 2010 Dec 1;185(11):6802-8. doi: 10.4049/jimmunol.1002118. Epub 2010 Oct 22.

6.

EGFR signaling blunts allergen-induced IL-6 production and Th17 responses in the skin and attenuates development and relapse of atopic dermatitis.

Zhang Z, Xiao C, Gibson AM, Bass SA, Khurana Hershey GK.

J Immunol. 2014 Feb 1;192(3):859-66. doi: 10.4049/jimmunol.1301062. Epub 2013 Dec 13.

7.

Cannabinoid 1 receptors in keratinocytes attenuate fluorescein isothiocyanate-induced mouse atopic-like dermatitis.

Gaffal E, Glodde N, Jakobs M, Bald T, Tüting T.

Exp Dermatol. 2014 Jun;23(6):401-6. doi: 10.1111/exd.12414.

PMID:
24750433
8.

Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair.

Kuo IH, Carpenter-Mendini A, Yoshida T, McGirt LY, Ivanov AI, Barnes KC, Gallo RL, Borkowski AW, Yamasaki K, Leung DY, Georas SN, De Benedetto A, Beck LA.

J Invest Dermatol. 2013 Apr;133(4):988-98. doi: 10.1038/jid.2012.437. Epub 2012 Dec 6.

9.

TSLP produced by keratinocytes promotes allergen sensitization through skin and thereby triggers atopic march in mice.

Leyva-Castillo JM, Hener P, Jiang H, Li M.

J Invest Dermatol. 2013 Jan;133(1):154-63. doi: 10.1038/jid.2012.239. Epub 2012 Jul 26.

10.

Epidermal barrier defects link atopic dermatitis with altered skin cancer susceptibility.

Cipolat S, Hoste E, Natsuga K, Quist SR, Watt FM.

Elife. 2014 May 5;3:e01888. doi: 10.7554/eLife.01888.

11.

Loss of sirtuin 1 (SIRT1) disrupts skin barrier integrity and sensitizes mice to epicutaneous allergen challenge.

Ming M, Zhao B, Shea CR, Shah P, Qiang L, White SR, Sims DM, He YY.

J Allergy Clin Immunol. 2015 Apr;135(4):936-45.e4. doi: 10.1016/j.jaci.2014.09.035. Epub 2014 Nov 7.

12.

The role of interleukin-17 in mouse models of atopic dermatitis and contact dermatitis.

Heo WI, Lee KE, Hong JY, Kim MN, Oh MS, Kim YS, Kim KW, Kim KE, Sohn MH.

Clin Exp Dermatol. 2015 Aug;40(6):665-71. doi: 10.1111/ced.12567. Epub 2015 Feb 16.

PMID:
25684357
13.

Requirement of MyD88 signaling in keratinocytes for Langerhans cell migration and initiation of atopic dermatitis-like symptoms in mice.

Didovic S, Opitz FV, Holzmann B, Förster I, Weighardt H.

Eur J Immunol. 2016 Apr;46(4):981-92. doi: 10.1002/eji.201545710. Epub 2016 Jan 18.

14.

Suppression of skin inflammation in keratinocytes and acute/chronic disease models by caffeic acid phenethyl ester.

Lim KM, Bae S, Koo JE, Kim ES, Bae ON, Lee JY.

Arch Dermatol Res. 2015 Apr;307(3):219-27. doi: 10.1007/s00403-014-1529-8. Epub 2014 Dec 12.

PMID:
25501505
15.

Correlation between serum thymus and activation-regulated chemokine levels and stratum corneum barrier function in healthy individuals and patients with mild atopic dermatitis.

Furue M, Matsumoto T, Yamamoto T, Takeuchi S, Esaki H, Chiba T, Yamaguchi H.

J Dermatol Sci. 2012 Apr;66(1):60-3. doi: 10.1016/j.jdermsci.2012.01.011. Epub 2012 Feb 16.

PMID:
22391243
16.

Periostin contributes to epidermal hyperplasia in psoriasis common to atopic dermatitis.

Arima K, Ohta S, Takagi A, Shiraishi H, Masuoka M, Ontsuka K, Suto H, Suzuki S, Yamamoto K, Ogawa M, Simmons O, Yamaguchi Y, Toda S, Aihara M, Conway SJ, Ikeda S, Izuhara K.

Allergol Int. 2015 Jan;64(1):41-8. doi: 10.1016/j.alit.2014.06.001. Epub 2014 Oct 23.

17.

The squamous cell carcinoma antigens as relevant biomarkers of atopic dermatitis.

Mitsuishi K, Nakamura T, Sakata Y, Yuyama N, Arima K, Sugita Y, Suto H, Izuhara K, Ogawa H.

Clin Exp Allergy. 2005 Oct;35(10):1327-33.

PMID:
16238792
18.

Inhibitory effect of 5,6-dihydroergosteol-glucoside on atopic dermatitis-like skin lesions via suppression of NF-κB and STAT activation.

Jung M, Lee TH, Oh HJ, Kim H, Son Y, Lee EH, Kim J.

J Dermatol Sci. 2015 Sep;79(3):252-61. doi: 10.1016/j.jdermsci.2015.06.005. Epub 2015 Jun 15.

PMID:
26100037
19.

DAMP molecules S100A9 and S100A8 activated by IL-17A and house-dust mites are increased in atopic dermatitis.

Jin S, Park CO, Shin JU, Noh JY, Lee YS, Lee NR, Kim HR, Noh S, Lee Y, Lee JH, Lee KH.

Exp Dermatol. 2014 Dec;23(12):938-41. doi: 10.1111/exd.12563.

PMID:
25308296
20.

Oleanolic acid acetate inhibits atopic dermatitis and allergic contact dermatitis in a murine model.

Choi JK, Oh HM, Lee S, Park JW, Khang D, Lee SW, Lee WS, Rho MC, Kim SH.

Toxicol Appl Pharmacol. 2013 May 15;269(1):72-80. doi: 10.1016/j.taap.2013.03.001. Epub 2013 Mar 13.

PMID:
23499868

Supplemental Content

Support Center